Addiction medicine eager to embrace AI

People with substance use disorders stand to benefit from healthcare AI just like any other patients. But they may have to wait a bit longer than most others since AI has only just begun to emerge in addiction medicine. 

An addiction specialist looks at the technology across healthcare, including his own professional backyard, in a paper surveying AI’s advance into clinical diagnostics and decision-making. Primary Care: Clinics in Office Practice published the work this month. 

Within addiction care, AI is being used to “predict relapse risk, identify patients who may benefit from specific treatments and improve patient outcomes in addiction recovery,” writes Nicholas Conley, MD, medical director at Apex Recovery Rehab in Franklin, Tennessee. 

Here’s a sampling of what else Conley observes about AI in his field and beyond. 

1. AI systems in addiction medicine focus on predicting relapse and tailoring interventions. 

For example, Conley notes, AI models that analyze patient behaviors, including social media activity and mobile phone usage, can detect early warning signs of relapse in patients with substance use disorders.

‘These systems provide real-time feedback to clinicians, enabling early interventions that can prevent relapse and improve treatment adherence.’

2. AI tools are being used to personalize addiction treatment. 

Machine learning models analyze patient data to recommend the most effective therapeutic interventions, such as cognitive-behavioral therapy, medication-assisted treatment or group therapy, Conley points out. 

‘By integrating data on past treatments, psychiatric conditions and social factors, AI models can optimize treatment plans for individuals, improving the chances of long-term recovery.’

3. As AI technologies mature, their role will expand across multiple specialties, offering diagnostic support, predictive analytics and personalized care. 

“However,” Conley writes, “realizing this potential requires careful attention to the development of AI systems that are transparent, explainable and aligned with the needs of healthcare providers.”

‘By fostering a collaborative relationship between AI and clinicians, AI-driven decision support will enhance, rather than replace, the role of healthcare professionals, creating a future where both technology and human expertise work together to provide better patient care.’

The paper is posted here.

• Other newsworthy research:
   
  • Carnegie Mellon University: AI models improve prediction of chronic kidney disease progression to end stage renal disease
     
  • Utrecht University: AI turns printer into a partner in tissue engineering